NCT01359566 Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01356940 A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT01356134 Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI) Status COMPLETED Phase N/A
NCT01339676 Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) Status UNKNOWN Phase PHASE4
NCT01339234 Supported Treadmill Training for Progressive Multiple Sclerosis Status COMPLETED Phase NA
NCT01333358 Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients Status UNKNOWN Phase PHASE3
NCT01330498 Longitudinal Pharmacokinetic, Pharmacodynamic, Immunological, and Biochemical Status COMPLETED Phase N/A
NCT01328379 Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01326715 Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT01324232 Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01318421 A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis Status TERMINATED Phase PHASE1
NCT01303770 Development and Evaluation of a Cognitive Rehabilitation Program for Persons With Multiple Sclerosis Status UNKNOWN Phase NA
NCT01299025 Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit Status COMPLETED Phase NA